Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Immunity|October 28, 2018
T-Cell-Intrinsic Receptor Interacting Protein 2 Regulates Pathogenic T Helper 17 Cell DifferentiationKenichi Shimada, Rebecca A Porritt, Janet L Markman, et al.Nature|August 21, 2020
C9orf72 in myeloid cells suppresses STING-induced inflammationMadelyn E McCauley, Jacqueline Gire O'Rourke, Alberto Yáñez, et al.ACS Nano|April 24, 2015
MRI virtual biopsy and treatment of brain metastatic tumors with targeted nanobioconjugates: nanoclinic in the brainRameshwar Patil, Alexander V Ljubimov, Pallavi R Gangalum, et al.Frontiers in Immunology|October 19, 2020
Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus ModelGantsetseg Tumurkhuu, Shuang Chen, Erica N Montano, et al.Nature Communications|February 1, 2020
Author Correction: Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapyAnna Galstyan, Janet L Markman, Ekaterina S Shatalova, et al.Nature Communications|August 30, 2019
Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapyAnna Galstyan, Janet L Markman, Ekaterina S Shatalova, et al.Nature Communications|November 27, 2020
Author Correction: Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapyAnna Galstyan, Janet L Markman, Ekaterina S Shatalova, et al.Frontiers in Oncology|October 24, 2024
Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapyNahum Puebla-Osorio, Natalie Wall Fowlkes, Hampartsoum B Barsoumian, et al.Journal for Immunotherapy of Cancer|May 16, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?Sonia Guedan, Maik Luu, Delphine Ammar, et al.Pageof 2